Early Dental Failure and Medication-related Osteonecrosis of the Jaw in Patients Treated with Bisphosphonates:A Meta-analysis of Pro-portions
10.11969/j.issn.1673-548X.2024.01.009
- VernacularTitle:使用双膦酸盐药物患者种植体早期失败率及术后药物相关性颌骨坏死的单组率Meta分析
- Author:
Peng YE
1
;
Shanshan ZHU
;
Zhiyue LU
Author Information
1. 100730 北京医院、国家老年医学中心、国家卫生健康委北京老年医学研究所、中国医学科学院老年医学研究院口腔科
- Keywords:
Bisphosphonates;
Dental implant;
Early failure;
Medication-related osteonecrosis of the jaw;
Meta-analysis
- From:
Journal of Medical Research
2024;53(1):36-40,183
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the early dental failure rate and medication-related osteonecrosis of the jaw(MRONJ)incidence in patients treated with bisphosphonates(BPs),and provide evidence for evaluation of clinical risk.Methods Electronic databases,in-cluding Cochrane Library,Wiley Online Library,PubMed,CNKI and Wanfang Data were searched to collect clinical studies concerning early dental failure and medication-related osteonecrosis of the jaw in patients treated with bisphosphonates.The data were collected from inception until May 2022.The meta-analysis was conducted using Stata 15.Osoftware.Results A total of 13 clinical observational stud-ies involving 1261 implants,wherein 1182 implants were placed in patients who took bisphosphonate orally,and 79 implants were placed in patients treated with intravenous bisphosphonate.In patients who had orally administrated bisphosphonates,the pooled early dental fail-ure rate was 1.7％(95％CI:0.3％-3.9％),and the MRONJ incidence was 0.Among patients treated with intravenous bisphospho-nate,the pooled early dental failure rate was 0,and the MRONJ incidence was 5.6％.Conclusion The early dental failure rate and MRONJ incidence in patients who take bisphosphonates orally is as low as in a healthy population.On account of the relatively high risk of post-operative MRONJ in patients treated with intravenous bisphosphonates,clinical indications must be opted prudently.
